XML 170 R33.htm IDEA: XBRL DOCUMENT v2.4.0.8
Fair Value of Financial Instruments (Tables)
 12 Months Ended
Jun. 30, 2013
Fair Value Disclosures [Abstract]  
Short-term Investments and Financial Instruments
The following table summarizes the valuation of the Company's remaining assets and liabilities measured at fair value on a recurring basis as of June 30, 2013:
 
Total
 
Quoted
prices  in
active
markets
(Level  1)
 
Significant
other
observable
inputs
(Level 2)
 
Significant
unobservable
inputs
(Level 3)
 
(in thousands)
Assets:
 
 
 
 
 
 
 
Deferred compensation plan investments, current and non-current portion
$
13,752

 
$
13,752

 
$
—

 
$
—

Forward foreign currency exchange contracts
308

 
—

 
308

 
—

Total assets at fair value
$
14,060

 
$
13,752

 
$
308

 
$
—

Liabilities:
 
 
 
 
 
 
 
Deferred compensation plan investments, current and non-current portion
$
13,752

 
$
13,752

 
$
—

 
$
—

Forward foreign currency exchange contracts
34

 
—

 
34

 
—

Liability for contingent consideration, current and non-current
12,545

 
—

 
—

 
12,545

Total liabilities at fair value
$
26,331

 
$
13,752

 
$
34

 
$
12,545



The following table presents assets and liabilities measured at fair value on a recurring basis as of June 30, 2012:

 
Total
 
Quoted
prices  in
active
markets
(Level  1)
 
Significant
other
observable
inputs
(Level 2)
 
Significant
unobservable
inputs
(Level 3)
 
(in thousands)
Assets:
 
 
 
 
 
 
 
Deferred compensation plan investments, current and non-current portion
$
11,635

 
$
11,635

 
$
—

 
$
—

Forward foreign currency exchange contracts
21

 
—

 
21

 
—

Total assets at fair value
$
11,656

 
$
11,635

 
$
21

 
$
—

Liabilities:
 
 
 
 
 
 
 
Deferred compensation plan investments, current and non-current portion
$
11,635

 
$
11,635

 
$
—

 
$
—

Forward foreign currency exchange contracts
110

 
—

 
110

 
—

Liability for contingent consideration, current and non-current
16,653

 
—

 
—

 
16,653

Total liabilities at fair value
$
28,398

 
$
11,635

 
$
110

 
$
16,653
Fair Value, Business Acquisition, Liability for Contingent Consideration
The table below provides a summary of the changes in fair value of the Company’s only financial asset or liability, the contingent consideration for the CDC earnout that is measured at fair value on a recurring basis using significant unobservable inputs (Level 3) for the year ended June 30, 2013 and 2012:
 
Contingent
Consideration for
the Year Ended 

 
Contingent
Consideration for
the Year Ended 

 
June 30, 2013
 
June 30, 2012
 
(in thousands)
Fair value at beginning of period
$
16,653

 
$
23,794

Payments
(4,777
)
 
(2,000
)
Change in fair value
1,843

 
120

Fluctuation due to foreign currency exchange
(1,174
)
 
(5,261
)
Fair value at end of period
$
12,545

 
$
16,653